Vermögenswerte Veränderung Datum
Adma Biologics USD 665.18M 40.94M 2026-03
Alnylam Pharmaceuticals USD 5.13B 163.22M 2026-03
BioCryst Pharmaceuticals USD 465.05M 49.11M 2026-03
Minerva Neurosciences USD 97.97M 69.88M 2025-12
Novavax USD 1.04B 133.35M 2026-03
Omeros USD 200.57M 34.59M 2025-06
Takeda JPY 15.45T 44.34B 2026-03